---
title: dFDA Cost-Benefit Analysis
description: Financial Modeling of the Decentralized FDA
---

This analysis models the health and economic benefits generated by the Decentralized FDA (dFDA) platform, which is funded by the "Captured Dividend" from the Peace Dividend analysis.

The model is based on the data in the full [dFDA Cost Benefit Analysis document](dfda-cost-benefit-analysis.qmd).

Key outputs of this model include:

- Projected annual R&D savings
- Return on Investment (ROI) for the dFDA Infrastructure
- Estimated health gains in Quality-Adjusted Life Years (QALYs)
- Sensitivity analysis on the key drivers of these benefits
- Rigorous Net Present Value (NPV) analysis

```{python}
import pandas as pd
import numpy_financial as npf
```


```{python}
# Import all parameters from single source of truth

import sys
import os

appendix_path = os.path.join(os.getcwd(), 'brain', 'book', 'appendix')
if appendix_path not in sys.path:
    sys.path.insert(0, appendix_path)

from economic_parameters import *

# Use parameters from economic_parameters.py

global_clinical_trial_market = GLOBAL_CLINICAL_TRIAL_MARKET_ANNUAL  # $100B
dfda_rd_cost_reduction_pct = TRIAL_COST_REDUCTION_PCT  # 50%
dfda_annual_operational_cost = DFDA_ANNUAL_OPEX  # $0.040B ($40M)

# Baseline QALYs generated annually

qaly_gains_annual_baseline = GLOBAL_DFDA_QALYS_GAINED_ANNUAL  # 840,000 QALYs
value_per_qaly = STANDARD_ECONOMIC_QALY_VALUE_USD  # $150,000 per QALY

# --- Calculations for dFDA Benefits ---

# Gross R&D savings

gross_rd_savings = DFDA_GROSS_SAVINGS_ANNUAL  # Pre-calculated: $50B

# Net R&D savings (after operational costs)

net_rd_savings = DFDA_NET_SAVINGS_ANNUAL  # Pre-calculated: $49.96B

# Simple ROI Calculation (not NPV-adjusted)
# ROI = (Gross Savings / Annual Opex)

dfda_roi_simple = DFDA_ROI_SIMPLE  # 1,250:1

# NPV-adjusted ROI (canonical figure)

dfda_roi_npv = ROI_DFDA_SAVINGS_ONLY  # 463:1 (from 10-year NPV analysis)

# Monetized value of QALY gains

monetized_qaly_value = DFDA_QALYS_MONETIZED  # $126B

# --- Connecting to the Peace Dividend ---
# The captured dividend must cover the operational cost.

captured_dividend = TREATY_ANNUAL_FUNDING  # $27.18B from 1% military redirect
funding_coverage_ratio = captured_dividend / dfda_annual_operational_cost  # 679.5x coverage

print(f"--- dFDA Cost-Benefit Analysis (Baseline) ---")
print(f"Annual Gross R&D Savings: ${gross_rd_savings:,.1f} Billion")
print(f"Annual dFDA Operational Cost: ${dfda_annual_operational_cost:,.3f} Billion")
print(f"Simple ROI (Gross/Opex): {dfda_roi_simple:,.0f}:1")
print(f"NPV-Adjusted ROI (10-year): {dfda_roi_npv:,.0f}:1  ‚Üê CANONICAL FIGURE")
print("-" * 45)
print(f"Annual QALYs Gained: {qaly_gains_annual_baseline:,.0f}")
print(f"Monetized Value of Annual QALYs: ${monetized_qaly_value:,.1f} Billion")
print("-" * 45)
print(f"Funding Coverage (Captured Dividend / OpEx): {funding_coverage_ratio:,.1f}x")
print("")
print("NOTE: The NPV-adjusted ROI (463:1) is the canonical figure used throughout")
print("the analysis. It accounts for time value of money and gradual adoption.")
print("The simple ROI (1,250:1) is useful for comparison but doesn't discount future cash flows.")
```

## dFDA Investment Returns Visualization

This chart shows the dramatic return on investment for the dFDA Infrastructure, comparing the small operational cost to the massive benefits it generates.

{{< include ../../../brain/figures/dfda-investment-returns-bar-chart.qmd >}}

## Sensitivity Analysis

This sensitivity analysis explores how the dFDA's financial viability, specifically its Return on Investment (ROI), changes under different assumptions. We test the two most critical drivers of the financial model:

1. **R&D Cost Reduction %**: The actual savings achieved could be lower or higher than our 50.0% baseline. We model a range from 30% to 70%.
2. **Annual Operational Cost**: The platform could be cheaper or more expensive to run than the estimated $40M. We model a range from $20M to $80M.

```{python}
# Define the ranges for the dFDA sensitivity analysis

rd_reduction_scenarios = [0.3, 0.4, 0.5, 0.6, 0.7]
operational_cost_scenarios = [0.020, 0.040, 0.060, 0.080] # In billions of USD

# Create an empty list to store results

dfda_results = []

# Loop through each combination of parameters

for redux_pct in rd_reduction_scenarios:
    for op_cost in operational_cost_scenarios:
        
        # Recalculate gross savings for this scenario
        gross_savings = global_clinical_trial_market * redux_pct
        
        # Recalculate ROI for this scenario
        # Handle case where op_cost is zero to avoid division error, though not in our scenarios
        if op_cost > 0:
            roi = gross_savings / op_cost
        else:
            roi = float('inf')

        # Store the result
        dfda_results.append({
            "R&D Reduction %": f"{redux_pct:.0%}",
            "Annual OpEx ($B)": f"${op_cost:.3f}",
            "ROI (x:1)": f"{roi:,.0f}"
        })

# Create and pivot the DataFrame

dfda_df = pd.DataFrame(dfda_results)
dfda_pivot = dfda_df.pivot(index="Annual OpEx ($B)", columns="R&D Reduction %", values="ROI (x:1)")

print("--- Sensitivity Analysis: dFDA Return on Investment (ROI) ---")
print(dfda_pivot)
```

## Rigorous Financial Model: Net Present Value (NPV) Analysis

The simple ROI calculation is useful for a high-level summary, but a more rigorous financial analysis uses **Net Present Value (NPV)**. This method accounts for the "time value of money" by using a discount rate to value future savings and costs in today's dollars. It provides a much more accurate picture of the investment's long-term value.

This model calculates:

1. The NPV of all costs (upfront and operational) over a 10-year horizon
2. The NPV of all savings (ramping up as the platform is adopted)
3. A more robust ROI and Net Benefit based on these NPV figures

```{python}
# NPV Model Parameters
# Source: brain/book/appendix/economic_parameters.py

# Costs (in billions USD) - from economic_parameters.py

C0 = DFDA_NPV_UPFRONT_COST_TOTAL  # $0.26975B (core platform + medium broader initiatives)
Cop = DFDA_NPV_ANNUAL_OPEX_TOTAL  # $0.04005B annual ops (core + broader initiatives)

# Savings (in billions USD) - from economic_parameters.py

Rd = GLOBAL_CLINICAL_TRIAL_MARKET_ANNUAL  # $100B annual global R&D spend on clinical trials
alpha = TRIAL_COST_REDUCTION_PCT  # 0.50 (50% reduction)

# Financial Parameters - from economic_parameters.py

r = NPV_DISCOUNT_RATE_STANDARD  # 0.08 (8% annual discount rate)
T = NPV_TIME_HORIZON_YEARS  # 10 years
adoption_ramp_years = DFDA_NPV_ADOPTION_RAMP_YEARS  # 5 years to full adoption

# Adoption Curve p(t)
# Linear ramp from 0% to 100% over adoption_ramp_years, then constant at 100%

def adoption_rate(t):
    if t == 0:
        return 0
    elif t <= adoption_ramp_years:
        return t / adoption_ramp_years
    else:
        return 1.0

# Calculate the annual savings for each year, considering the adoption rate
# This is needed for the NPV visualization

annual_savings_stream = [(adoption_rate(t) * alpha * Rd) for t in range(1, T + 1)]

print("NPV Model Parameters Loaded from economic_parameters.py")
print(f"Upfront Cost (C0): ${C0:.4f}B")
print(f"Annual OpEx (Cop): ${Cop:.4f}B")
print(f"Discount Rate (r): {r:.0%}")
print(f"Time Horizon (T): {T} years")
print(f"Adoption Ramp: {adoption_ramp_years} years to 100%")
```

```{python}
# --- NPV of Costs ---
# Create a stream of operational costs over the time horizon

operational_costs_stream = [Cop] * T
# The npv function in numpy_financial takes the rate and a stream of cash flows.
# It assumes the first cash flow is at t=1.

npv_of_ops = npf.npv(r, operational_costs_stream)
# Total NPV of costs is the upfront cost plus the discounted stream of operational costs

npv_costs = C0 + npv_of_ops

# --- NPV of Savings ---
# Calculate the NPV of this savings stream

npv_savings = npf.npv(r, annual_savings_stream)

# --- Final ROI and Net Benefit ---

robust_roi = npv_savings / npv_costs
net_benefit = npv_savings - npv_costs

# --- Display Results ---

print("--- Rigorous Financial Analysis Results ---")
print(f"NPV of Total Costs over {T} years: ${npv_costs:,.3f} Billion")
print(f"NPV of Total Savings over {T} years: ${npv_savings:,.3f} Billion")
print("-" * 40)
print(f"Net Benefit (NPV Savings - NPV Costs): ${net_benefit:,.3f} Billion")
print(f"Robust ROI (NPV Savings / NPV Costs): {robust_roi:,.0f}:1")
```

## NPV Analysis Over Time

This chart shows how the investment pays back over time, accounting for the time value of money and the gradual adoption of the platform.

{{< include ../../../brain/figures/dfda-npv-analysis-over-time-line-chart.qmd >}}

## Key Findings

The dFDA cost-benefit analysis reveals:

1. **Exceptional ROI**: The platform generates a 1,250:1 return on investment ($50.0B savings from $40M cost)
2. **Massive Health Benefits**: 840,000 QALYs gained annually, worth $126 billion in monetized value
3. **Robust Financial Model**: NPV analysis confirms strong returns even with conservative assumptions
4. **Self-Funding**: The captured peace dividend ($27.2B) easily covers operational costs ($40M)
5. **Sensitivity Resilience**: ROI remains strong even under conservative scenarios (30% cost reduction, higher operational costs)

This analysis demonstrates that the dFDA represents one of the most compelling investment opportunities in human history, combining massive financial returns with unprecedented health benefits.
